My Special Aflac Duck® lands in the Sacramento Valley
Aflac donated robotic companion ducks to Keaton's Child Cancer Alliance in Roseville, marking nearly 200 ducks given to the organization in two years. The My Special Aflac Duck, a social robot designed to help children during cancer treatment, has been distributed to over 33,000 recipients since 2018. A three-year study showed the duck helps reduce distress, nausea, pain, and procedural anxiety in patients, while also decreasing stress in caregivers. The program is part of Aflac's $184 million commitment to pediatric cancer and blood disorder treatment. The robotic companions are available free of charge to children 3 years or older diagnosed with cancer or sickle cell disease.
Aflac ha donato anatre robotiche compagne alla Keaton's Child Cancer Alliance di Roseville, segnando quasi 200 anatre donate all'organizzazione in due anni. Il My Special Aflac Duck, un robot sociale progettato per aiutare i bambini durante il trattamento del cancro, è stato distribuito a oltre 33.000 destinatari dal 2018. Uno studio triennale ha dimostrato che l'anatra aiuta a ridurre il disagio, la nausea, il dolore e l'ansia procedurale nei pazienti, riducendo anche lo stress nei caregiver. Il programma fa parte dell'impegno di Aflac di 184 milioni di dollari per il trattamento del cancro pediatrico e dei disturbi del sangue. I compagni robotici sono disponibili gratuitamente per i bambini di 3 anni o più diagnosticati con cancro o malattia delle cellule falciformi.
Aflac donó patos robóticos compañeros a la Keaton's Child Cancer Alliance en Roseville, marcando casi de casi casi 200 patos donados a la organización en dos años. El My Special Aflac Duck, un robot social diseñado para ayudar a los niños durante el tratamiento del cáncer, se ha distribuido a más de 33,000 beneficiarios desde 2018. Un estudio de tres años mostró que el pato ayuda a reducir la angustia, las náuseas, el dolor y la ansiedad por los procedimientos en los pacientes, al tiempo que disminuye el estrés en los cuidadores. El programa es parte del compromiso de Aflac de 184 millones de dólares para el tratamiento del cáncer pediátrico y los trastornos sanguíneos. Los compañeros robóticos están disponibles de forma gratuita para niños de 3 años o más diagnosticados con cáncer o anemia de células falciformes.
Aflac는 Roseville에 있는 Keaton's Child Cancer Alliance에 로봇 친구 오리를 기부하며, 2년 동안 해당 기관에 거의 200마리의 오리를 기부한 기록을 세웠습니다. My Special Aflac Duck는 암 치료 중 아동을 돕기 위해 설계된 사회적 로봇으로, 2018년 이후로 33,000명 이상의 수령자에게 배포되었습니다. 3년 연구에 따르면 이 오리는 환자의 불안, 메스꺼움, 통증 및 절차적 불안을 줄이는 데 도움이 되며, 보호자의 스트레스도 감소시키는 것으로 나타났습니다. 이 프로그램은 소아암 및 혈액 질환 치료를 위한 Aflac의 1억 8400만 달러의 약속의 일환입니다. 로봇 친구는 암이나 겸상 적혈구병 진단을 받은 3세 이상의 아동에게 무료로 제공됩니다.
Aflac a fait don de canards robotiques compagnons à la Keaton's Child Cancer Alliance à Roseville, marquant près de 200 canards offerts à l'organisation en deux ans. Le My Special Aflac Duck, un robot social conçu pour aider les enfants pendant leur traitement contre le cancer, a été distribué à plus de 33 000 destinataires depuis 2018. Une étude de trois ans a montré que le canard aide à réduire la souffrance, les nausées, la douleur et l'anxiété procédurale chez les patients, tout en diminuant le stress des aidants. Ce programme fait partie de l'engagement d'Aflac de 184 millions de dollars pour le traitement du cancer pédiatrique et des troubles sanguins. Les compagnons robotiques sont disponibles gratuitement pour les enfants de 3 ans ou plus diagnostiqués avec un cancer ou une maladie des cellules falciformes.
Aflac spendete robotische Begleitentenente an die Keaton's Child Cancer Alliance in Roseville, womit nahezu 200 Enten in zwei Jahren an die Organisation gespendet wurden. Die My Special Aflac Duck, ein sozialer Roboter, der dazu entwickelt wurde, Kindern während der Krebsbehandlung zu helfen, wurde seit 2018 an über 33.000 Empfänger verteilt. Eine dreijährige Studie zeigte, dass die Ente hilft, Stress, Übelkeit, Schmerzen und prozedurale Angst bei Patienten zu reduzieren, während sie auch den Stress bei Betreuern verringert. Das Programm ist Teil von Aflacs Engagement von 184 Millionen Dollar für die Behandlung von pädiatrischem Krebs und Blutkrankheiten. Die robotischen Begleiter sind kostenfrei für Kinder ab 3 Jahren erhältlich, die an Krebs oder Sichelzellenanämie erkrankt sind.
- Three-year study demonstrates proven medical benefits in reducing patient distress and anxiety
- Program has successfully distributed over 33,000 ducks since 2018
- Part of substantial $184 million commitment to pediatric cancer treatment
- None.
Insights
The My Special Aflac Duck program represents a meaningful but financially modest corporate social responsibility initiative. While the program has distributed
The three-year study showing reduced distress and anxiety in patients demonstrates positive outcomes, but from an investment perspective, this initiative primarily serves to enhance brand reputation and corporate goodwill rather than drive significant revenue or earnings growth. The program's expansion to Northern California and continued distribution milestones (33,000 ducks since 2018) indicate steady execution of Aflac's CSR strategy without material financial implications.
Comforting robotic companions donated to pediatric cancer patients courtesy of Aflac
"Approximately 26 children are diagnosed with cancer each day in
My Special Aflac Duck is a social robot powered by innovative technology that helps kids prepare for medical procedures, communicate their feelings, practice distraction techniques and more. The robotic companion was designed in consult with more than 100 children, families and medical professionals in conjunction with Empath Labs.
A three-year study revealed that patients reported a reduction in distress, nausea, pain and procedural anxiety compared to those in the study who had not yet received a duck. In addition, parents and caregivers reported a reduction in stress and anxiety, showing how My Special Aflac Duck helps children's support system.
The duck delivery Thursday coincided with Keaton's annual Operation Gobble, where more than 20 families received Thanksgiving meal kits.
"We are incredibly grateful for our partnership with Aflac to ensure that young cancer warriors and their families receive the personalized support they need throughout their journey" said Jessica Alonso, Executive Director of Keaton's Child Cancer Alliance. "This generous contribution of My Special Aflac Ducks will have a meaningful impact on the children we serve. These comforting, interactive companions provide emotional support and help children navigate the complexities of treatment, bringing much-needed smiles and strength to families during some of their most challenging moments. Together, we are empowering those we serve to face cancer with courage and hope."
Since its debut in 2018, My Special Aflac Duck has received numerous awards; it was named one of Time Magazine's 50 Best Inventions and collected the Best in Show at CES and South by Southwest, among others. The My Special Aflac Duck program is a hallmark of Aflac's more than
Health care providers, support organizations and families can order My Special Aflac Duck free of charge for children 3 years or older who have been diagnosed with cancer or sickle cell disease at MySpecialAflacDuck.com.
ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than 68 years to millions of policyholders and customers through its subsidiaries in the
1 LIMRA 2023 U.S. Supplemental Health Insurance Total Market Report
Media contact: Jon Sullivan, 706-763-4813 or jsullivan@aflac.com
Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or dyoung@aflac.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/my-special-aflac-duck-lands-in-the-sacramento-valley-302313728.html
SOURCE Aflac
FAQ
How many My Special Aflac Ducks have been distributed since 2018?
What medical benefits does the My Special Aflac Duck provide to cancer patients?
How much has Aflac (AFL) invested in pediatric cancer and blood disorder treatment?